R. Jakesz

Researcher Next ID · RN-040128

Researcher · Biochemistry, Genetics and Molecular Biology

Comprehensive Cancer Center Vienna

Vienna, Austria

Accepting doctoral researchersFunding unknown

Works count: 530
Citation count: 20,948
H-index: 71
i10-index: 226

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Breast Cancer Treatment Studies

Estrogen and related hormone effects

Cancer Treatment and Pharmacology

Advanced Breast Cancer Therapies

Breast Lesions and Carcinomas

Publications

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2104162
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30777-5
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)60995-3
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
Annals of Oncology · 2014 · https://doi.org/10.1093/annonc/mdu544
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mdt494
A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
Clinical Cancer Research · 2011 · https://doi.org/10.1158/1078-0432.ccr-11-0926
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
New England Journal of Medicine · 2009 · https://doi.org/10.1056/nejmoa0806285
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2009.23.1274
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
The Lancet · 2005 · https://doi.org/10.1016/s0140-6736(05)67059-6

Current projects

No projects listed.